CASI Pharma (CASI) Misses Q3 EPS by 67c

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Iran deal reopens Strait of Hormuz - Reuters
• Nvidia pitches Vera CPU to Chinese clients with August delivery target